MedElevator Войти в исследования
← Поиск публикаций

DOI 10.14309/ajg.0000000000003732

Медицинская библиотека · The American journal of gastroenterology · 2025

Safety of Esophageal Dilation Procedures in Patients on Antithrombotic Therapy: A Propensity-Matched Cohort Study.

Elfert Khaled, Ismail Abdellatif, Abusuliman Mohammed, Eldesouki Mohamed, Aloum Khalid, Kloub Mohammad, Elghayesh Mahmoud, Passalacqua Karla, Abosheaishaa Hazem, Nassar Mahmoud, Kupec Justin, Krafft Matthew, Elhanafi Sherif E

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Esophageal dilation procedures are frequently performed on patients who are taking antithrombotic medications. The aim of this study was to evaluate whether patients on antithrombotic therapies have an increased risk of bleeding from esophageal dilation.

METHODS

A retrospective propensity-matched cohort study was conducted to evaluate patients in the TriNetX US Collaborative Network database who underwent esophageal dilation procedures. The primary outcome was to assess the effect of anticoagulants and dual-antiplatelet therapies (DAPTs) on the rate of postprocedural gastrointestinal bleeding within 30 days.

RESULTS

Patients on anticoagulants were found to be at higher risk of postprocedural gastrointestinal bleeding compared with patients not on anticoagulants (relative risk [RR], 1.43; 95% confidence interval [CI], 1.06-1.92; P  = 0.017). The anticoagulant group had higher rates of blood transfusion and intensive care unit admission. The DAPT group had a higher rate of gastrointestinal bleeding compared with no antiplatelet therapy, though this did not reach statistical significance (RR, 1.64; 95% CI, 0.97-2.75; P = 0.06). When compared with aspirin monotherapy, the difference in bleeding rates was also not statistically significant (RR, 1.36; 95% CI, 0.84-2.19; P = 0.2). There was no difference in the rates of blood transfusion or intensive care unit admission when DAPT was compared separately with aspirin and with no antiplatelet groups. In addition, early resumption of anticoagulation or antiplatelet therapy was not associated with increased postprocedural bleeding.

DISCUSSION: Patients on anticoagulants at the time of esophageal dilation were at higher risk of postprocedural bleeding. DAPT was numerically associated with a higher risk of bleeding, but this did not reach statistical significance. These findings aim to inform the clinical decision making in preprocedure and postprocedure management of esophageal dilation procedures.

Для цитирования: Elfert Khaled, Ismail Abdellatif, Abusuliman Mohammed, Eldesouki Mohamed, Aloum Khalid, Kloub Mohammad, Elghayesh Mahmoud, Passalacqua Karla, Abosheaishaa Hazem, Nassar Mahmoud, Kupec Justin, Krafft Matthew, Elhanafi Sherif E. Safety of Esophageal Dilation Procedures in Patients on Antithrombotic Therapy: A Propensity-Matched Cohort Study.. The American journal of gastroenterology. 2025. DOI: 10.14309/ajg.0000000000003732.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.